---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-026319"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2022-02-24T23:59:59+00:00"
generated_at: "2026-06-27T04:56:30.705569+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Elanco FY21 rev $4,765M, adj EPS $1.05; Q4 adj EPS $0.21 (+75%); FY22 adj EPS guidance $1.18-1.24

## Summary
- Full year 2021 revenue $4,765M (+46% YoY); reported EPS -$0.97, adjusted EPS $1.05.
- Q4 2021 revenue $1,113M (-2% YoY); adjusted EPS $0.21 (+75% YoY).
- FY22 guidance: revenue $4,745-$4,800M, adjusted EPS $1.18-$1.24.
- Restructuring: ~380 positions cut; synergy target raised to $345M by 2023.
- Board eliminated supermajority voting and adopted proxy access for 3%+ shareholders owning ≥3 years.

## SEC filing metadata
- accession: 0001104659-22-026319
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2022-02-24T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465922026319/0001104659-22-026319-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465922026319/tm227491d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-026319
- JSON: https://secwatch.observer/filing/0001104659-22-026319.json
- Plain text: https://secwatch.observer/filing/0001104659-22-026319.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.